Evidence map›Paper›PMID 29678903›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Adjuvant Therapy for Colon Cancer: Genes, Genes… and the Patient in the Center.

Javier Rodriguez, Silvestre Vicent, Ana Chopitea, Mariano Ponz-Sarvisé

Abstract readComment
PubMed Publisher
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Javier RodriguezMedical Oncology Department, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Silvestre VicentNavarra Institute for Health Research, IdiSNA, Pamplona, Spain.
Ana ChopiteaMedical Oncology Department, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Mariano Ponz-SarviséMedical Oncology Department, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain. mponz@unav.es.ORCID 0000-0002-3240-729X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although molecular subtype-based stratification and genomic signatures of increasing complexity are becoming a new strategy to guide therapeutic decisions in stage II/III colon cancer, several prognostic factors that can be easily obtained from formalin-fixed paraffin-embedded (FFPE) specimens should be considered to create combined models that better define individual patients' needs.

Indexed as

Colonic NeoplasmsColorectal NeoplasmsMicroRNAsGene Expression ProfilingHumansNeoplasm Recurrence, LocalMicroRNAs

Identifiers

PMID29678903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.